# Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation

> **NCT02175589** · PHASE2 · UNKNOWN · sponsor: **Rambam Health Care Campus** · enrollment: 80 (estimated)

## Conditions studied

- Familial Mediterranean Fever

## Interventions

- **OTHER:** Colchicine Cessation

## Key facts

- **NCT ID:** NCT02175589
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2014-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02175589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02175589, "Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02175589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*